前列腺穿刺活检研究进展
Research Progress on Prostate Biopsy
DOI: 10.12677/ACM.2022.121065, PDF,   
作者: 徐 驰:延安大学医学院,陕西 延安;高继学*:延安大学附属医院泌尿外科,陕西 延安
关键词: 前列腺穿刺活检前列腺癌靶向穿刺Prostate Biopsy Prostate Cancer Targeted Biopsy
摘要: 近年来,我国的前列腺癌发病率逐渐增高,前列腺穿刺活检仍然是确诊前列腺癌的“金标准”,然而,临床上存在较多不必要的前列腺穿刺活检,关于前列腺穿刺活检适应症、方法、针数和相关并发症等方面仍有不同的认识,本文就前列腺穿刺活检的适应症、方法、针数和相关并发症等方面的综述如下。
Abstract: In recent years, the incidence of prostate cancer is increasing in China. Prostate biopsy remains the gold standard for the diagnosis of prostate cancer. However, there are many unnecessary prostate biopsies in clinical practice and various opinions about biopsy indications, biopsy methods, number of biopsy cores and biopsy related complications. So, this review focuses on these factors.
文章引用:徐驰, 高继学. 前列腺穿刺活检研究进展[J]. 临床医学进展, 2022, 12(1): 431-437. https://doi.org/10.12677/ACM.2022.121065

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Ye, D. and Zhu, Y. (2015) Epidemiology of Prostate Cancer in China: An Overview and clinical Implication. Chinese Journal of Surgery, 53, 249-252.
[3] Walsh, A.L., Considine, S.W., Thomas, A.Z., Lynch, T.H. and Manecksha, R.P. (2014) Digital Rectal Examination in Primary Care Is Important for Early Detection of Prostate Cancer: A Retrospective Cohort Analysis Study. British Journal of General Practice, 64, e783-e787. [Google Scholar] [CrossRef
[4] Naji, L., Randhawa, H., Sohani, Z., Dennis, B., Lautenbach, D., Kavanagh, O., Bawor, M., Banfield, L. and Profetto, J. (2018) Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis. Annals of Family Medicine, 16, 149-154. [Google Scholar] [CrossRef] [PubMed]
[5] Caliskan, S. (2017) Diagnostic Efficacy of Free Prostate-Specific Antigen/Total Prostate-Specific Antigen Ratio for the Diagnosis of Prostate Cancer in Low Concentration (≤4 ng/ml) and Intermediate Levels of Total Prostate-Specific Antigen (4.01-10.0 ng/ml). Journal of Cancer Research and Therapeutics, 13, 279-283. [Google Scholar] [CrossRef] [PubMed]
[6] Catalona, W.J., Smith, D.S., Wolfert, R.L., Wang, T.J., Rittenhouse, H.G., Ratliff, T. and Nadler, R.B. (1995) Evaluation of Percentage of Free Serum Prostate-Specific Antigen to Improve Specificity of Prostate Cancer Screening. JAMA, 274, 1214-1220. [Google Scholar] [CrossRef] [PubMed]
[7] Teoh, J.Y., Yuen, S.K., Tsu, J.H., Wong, C.K., Ho, B.S., Ng, A.T., Ma, W.K., Ho, K.L. and Yiu, M.K. (2017) The Performance Characteristics of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Chinese Men. Asian Journal of Andrology, 19, 113-116.
[8] Aganovic, D., Prcic, A., Kulovac, B. and Hadziosmanovic, O. (2012) Influence of the Prostate Volume, Prostate Specific Antigen Density and Number of Biopsy Samples on Prostate Cancer Detection. Medical Archives, 66, 41-44. [Google Scholar] [CrossRef] [PubMed]
[9] Loeb, S., Roehl, K.A., Catalona, W.J. and Nadler, R.B. (2007) Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men. The Journal of Urology, 177, 899-902. [Google Scholar] [CrossRef] [PubMed]
[10] Totaro, A., Di Gianfrancesco, L., Pinto, F., Racioppi, M., Palermo, G., Campetella, M., Santoro, A.A., Arbia, G. and Sacco, E. (2021) Rate of Clinically Significant Prostate Cancer on Repeat Saturation Biopsy after a Diagnosis of Atypical Small Acinar Proliferation. Urologia, 88, 194-199. [Google Scholar] [CrossRef] [PubMed]
[11] Pradere, B., Veeratterapillay, R., Dimitropoulos, K., Yuan, Y., Omar, M.I., MacLennan, S., Cai, T., Bruyère, F., Bartoletti, R., Köves, B., Wagenlehner, F., Bonkat, G. and Pilatz, A. (2021) Nonantibiotic Strategies for the Prevention of Infectious Complications Following Prostate Biopsy: A Systematic Review and Meta-Analysis. The Journal of Urology, 205, 653-663. [Google Scholar] [CrossRef
[12] Hossack, T., Patel, M.I., Huo, A., Brenner, P., Yuen, C., Spernat, D., Mathews, J., Haynes, A.M., Sutherland, R., del Prado, W. and Stricker, P. (2012) Location and Pathological Characteristics of Cancers in Radical Prostatectomy Specimens Identified by Transperineal Biopsy Compared to Transrectal Biopsy. The Journal of Urology, 188, 781-785. [Google Scholar] [CrossRef] [PubMed]
[13] Crawford, E.D., Rove, K.O., Barqawi, A.B., Maroni, P.D., Werahera, P.N., Baer, C.A., Koul, H.K., Rove, C.A., Lucia, M.S. and La Rosa, F.G. (2013) Clinical-Pathologic Correlation between Transperineal Mapping Biopsies of the Prostate and Three-Dimensional Reconstruction of Prostatectomy Specimens. Prostate, 73, 778-87. [Google Scholar] [CrossRef] [PubMed]
[14] van der Leest, M., Cornel, E., Israël, B., Hendriks, R., Padhani, A.R., Hoogenboom, M., Zamecnik, P., Bakker, D., Setiasti, A.Y., Veltman, J., van den Hout, H., van der Lelij, H., van Oort, I., Klaver, S., Debruyne, F., Sedelaar, M., Hannink, G., Rovers, M., Hulsbergen-van de Kaa, C. and Barentsz, J.O. (2019) Head-to-Head Comparison of Transrectal Ultrasound-Guided Prostate Biopsy versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-Guided Biopsy in Biopsy-Naïve Men with Elevated Prostate-Specific Antigen: A Large Prospective Multicenter Clinical Study. European Urology, 75, 570-578. [Google Scholar] [CrossRef] [PubMed]
[15] Baboudjian, M., Bandelier, Q., Gondran-Tellier, B., Abdallah, R., Michel, F., Sichez, P.C., Di-Crocco, E., Akiki, A., Gaillet, S., Delaporte, V. andre, M., Daniel, L., Karsenty, G., Lechevallier, E. and Boissier, R. (2020) MRI-Targeted Biopsy for Detecting Prostate Cancer: Have the Guidelines Changed Our Practices and Our Prostate Cancer Detection Rate? International Urology and Nephrology, 52, 611-618. [Google Scholar] [CrossRef] [PubMed]
[16] Oberlin, D.T., Casalino, D.D., Miller, F.H., Matulewicz, R.S., Perry, K.T., Nadler, R.B., Kundu, S., Catalona, W.J. and Meeks, J.J. (2016) Diagnostic Value of Guided Biopsies: Fusion and Cognitive-Registration Magnetic Resonance Imaging versus Conventional Ultrasound Biopsy of the Prostate. Urology, 92, 75-79. [Google Scholar] [CrossRef] [PubMed]
[17] Hanna, N., Wszolek, M.F., Mojtahed, A., Nicaise, E., Wu, B., Gelpi-Hammerschmidt, F.J., Salari, K., Dahl, D.M., Blute, M.L., Harisinghani, M. and Feldman, A.S. (2019) Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. The Journal of Urology, 202, 944-951. [Google Scholar] [CrossRef
[18] BarbasBernardos, G., Herranz Amo, F., de Miguel Campos, E., Luis Cardo, A., Herranz Arriero, A., Cancho Gil, M.J., Caño Velasco, J., JaraRascón, J., Mayor de Castro, J. and Hernández Fernández, C. (2019) Comparison of Classical Transrectal Prostate Biopsy versus Cognitive Registration in Rebiopsy. Actas Urológicas Españolas (Engl Ed). 43, 228-233. [Google Scholar] [CrossRef
[19] Soga, N., Yatabe, Y., Ogura, Y. and Hayashi, N. (2015) Additional Midline Biopsies of the Peripheral Zone Associated with the First Endorectal Standard Sextant Pattern Improves the Accuracy of Prostate Cancer Detection in Japanese Patients. Current Urology, 8, 74-78. [Google Scholar] [CrossRef] [PubMed]
[20] Scattoni, V., Roscigno, M., Raber, M., Dehò, F., Maga, T., Zanoni, M., Riva, M., Sangalli, M., Nava, L., Mazzoccoli, B., Freschi, M., Guazzoni, G., Rigatti, P. and Montorsi, F. (2008) Initial Extended Transrectal Prostate Biopsy—Are More Prostate Cancers Detected with 18 Cores than with 12 Cores? The Journal of Urology, 179, 1327-1331. [Google Scholar] [CrossRef] [PubMed]
[21] Ghafoori, M., Velayati, M., AliyariGhasabeh, M., Shakiba, M. and Alavi, M. (2015) Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications. Iranian Journal of Radiology, 12, e13257. [Google Scholar] [CrossRef] [PubMed]
[22] Ploussard, G., Nicolaiew, N., Marchand, C., Terry, S., Vacherot, F., Vordos, D., Allory, Y., Abbou, C.C., Salomon, L. and de la Taille, A. (2014) Prospective Evaluation of an Extended 21-Core Biopsy Scheme as Initial Prostate Cancer Diagnostic Strategy. European Urology, 65, 154-161. [Google Scholar] [CrossRef] [PubMed]
[23] Guo, G., Xu, Y. and Zhang, X. (2017) TRUS-Guided Transperineal Prostate 12+X Core Biopsy with Template for the Diagnosis of Prostate Cancer. Oncology Letters, 13, 4863-4867. [Google Scholar] [CrossRef] [PubMed]
[24] Borghesi, M., Ahmed, H., Nam, R., Schaeffer, E., Schiavina, R., Taneja, S., Weidner, W. and Loeb, S. (2017) Complications after Systematic, Random, and Image-Guided Prostate Biopsy. European Urology, 71, 353-365. [Google Scholar] [CrossRef] [PubMed]
[25] Raaijmakers, R., Kirkels, W.J., Roobol, M.J., Wildhagen, M.F. and Schrder, F.H. (2002) Complication Rates and Risk Factors of 5802 Transrectal Ultrasound-Guided Sextant Biopsies of the Prostate within a Population-Based Screening Program. Urology, 60, 826-830. [Google Scholar] [CrossRef
[26] Nam, R.K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L.H., Loblaw, D.A., Trachtenberg, J., Stanimirovic, A., Simor, A.E., Seth, A., Urbach, D.R. and Narod, S.A. (2013) Increasing Hospital Admission Rates for Urological Complications after Transrectal Ultrasound Guided Prostate Biopsy. The Journal of Urology, 189, S12-S17. [Google Scholar] [CrossRef] [PubMed]